These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26568600)

  • 21. Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial.
    Kreiner F; Galbo H
    Arthritis Res Ther; 2010; 12(5):R176. PubMed ID: 20854662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients.
    Quartuccio L; Gregoraci G; Isola M; De Vita S
    Geriatr Gerontol Int; 2018 Sep; 18(9):1410-1414. PubMed ID: 29978586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA; Garcia-Porrua C; Miranda-Filloy JA; Martin J
    Drugs Aging; 2006; 23(8):627-49. PubMed ID: 16964987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
    Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
    Catanoso MG; Macchioni P; Boiardi L; Pipitone N; Salvarani C
    Arthritis Rheum; 2007 Dec; 57(8):1514-9. PubMed ID: 18050171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies.
    Kloppenburg M; Bøyesen P; Visser AW; Haugen IK; Boers M; Boonen A; Conaghan PG; Hawker GA; Kvien TK; Landewé R; Uhlig T; Smeets W; Greibrokk E; van der Heijde DM
    J Rheumatol; 2015 Nov; 42(11):2190-7. PubMed ID: 26136489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on treatment of polymyalgia rheumatica.
    Camellino D; Dejaco C
    Reumatismo; 2018 Mar; 70(1):59-66. PubMed ID: 29589404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
    Cleuziou C; Binard A; De Bandt M; Berthelot JM; Saraux A
    J Rheumatol; 2012 Feb; 39(2):310-3. PubMed ID: 22174199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of criteria for polymyalgia rheumatica.
    Bird HA; Esselinckx W; Dixon AS; Mowat AG; Wood PH
    Ann Rheum Dis; 1979 Oct; 38(5):434-9. PubMed ID: 518143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polymyalgia rheumatica].
    Kaposi Novák P; Schmidt Z
    Orv Hetil; 2006 Sep; 147(37):1791-802. PubMed ID: 17131799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome.
    Muller S; Hider S; Helliwell T; Partington R; Mallen C
    Reumatismo; 2018 Mar; 70(1):23-34. PubMed ID: 29589400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity.
    Cimmino MA; Parodi M; Montecucco C; Caporali R
    BMC Musculoskelet Disord; 2011 May; 12(1):94. PubMed ID: 21569559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.
    Leeb BF; Rintelen B; Sautner J; Fassl C; Bird HA
    Arthritis Rheum; 2007 Jun; 57(5):810-5. PubMed ID: 17530664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyalgia rheumatica can recur years after discontinuation of corticosteroid therapy.
    Docken WP
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S25-7. PubMed ID: 19646342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitions of and Instruments for Disease Activity, Remission, and Relapse in Polymyalgia Rheumatica: A Systematic Literature Review.
    Bolhuis TE; Bosch P; Falzon L; Owen CE; Yates M; Mackie SL; van der Maas A; Dejaco C
    Rheumatology (Oxford); 2024 Aug; ():. PubMed ID: 39133187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polymyalgia rheumatica].
    Schmidt WA
    Z Rheumatol; 2013 Feb; 72(1):59-65; quiz 66-7. PubMed ID: 23392601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymyalgia rheumatica: An updated review.
    Mahmood SB; Nelson E; Padniewski J; Nasr R
    Cleve Clin J Med; 2020 Aug; 87(9):549-556. PubMed ID: 32868305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.